Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.48 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.47 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14840738 | 0.90 | MEN1 (0.68) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL14852999 | 0.85 | MEN1 (0.53) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL14852996 | 0.83 | MEN1 (0.68) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL14013320 | 0.80 | MEN1 (0.52) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL13525202 | 0.79 | MEN1 (1.00) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL14853113 | 0.79 | MEN1 (0.55) | MEN1THRBRECQLBLMKMT2A | |
| Hydrochloric Acid SCHEMBL16295013 | 0.78 | MEN1 (0.98) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL31716158 | 0.78 | MEN1 (0.54) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL9350134 | 0.78 | MEN1 (0.54) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL13524213 | 0.78 | MEN1 (0.75) | MEN1THRBRECQLBLMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11939350-B2 | Fluorescent dyes and methods of use thereof | ENZO LIFE SCIENCES, INC. (US) | 2024-03-26 | — | — | US | disclosed |
| US-20210079034-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | ENZO LIFE SCIENCES, INC. (US) | 2021-03-18 | — | — | US | disclosed |
| US-20210079034-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | ENZO LIFE SCIENCES, INC. (US) | 2021-03-18 | — | — | US | disclosed |
| US-10875886-B2 | Fluorescent dyes and methods of use thereof | ENZO LIFE SCIENCES, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| US-10875886-B2 | Fluorescent dyes and methods of use thereof | ENZO LIFE SCIENCES, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| EP-3747877-A1 | FLUORESCENT DYES | Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. (US) | 2020-12-09 | — | — | EP | disclosed |
| EP-2768306-B1 | FLUORESCENT DYES | ENZO LIFE SCIENCES INC (US) | 2020-07-01 | — | — | EP | disclosed |
| US-20190002491-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) | 2019-01-03 | — | — | US | disclosed |
| US-20190002491-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) | 2019-01-03 | — | — | US | disclosed |
| US-10106573-B2 | Fluorescent dyes and methods of use thereof | ENZO LIFE SCIENCES, INC. (US) | 2018-10-23 | — | — | US | disclosed |
| US-20160311846-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) | 2016-10-27 | — | — | US | disclosed |
| US-9416153-B2 | Fluorescent dyes | ENZO LIFE SCIENCES, INC. (US) | 2016-08-16 | — | — | US | disclosed |
| EP-2768306-A1 | FLUORESCENT DYES | Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. (US) | 2014-08-27 | — | — | EP | disclosed |
| WO-2013055647-A1 | FLUORESCENT DYES | ENZO LIFE SCIENCES, INC. (US) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013055647-A1 | FLUORESCENT DYES | ENZO LIFE SCIENCES, INC. (US) | 2013-04-18 | — | — | WO | disclosed |
| US-20130089853-A1 | FLUORESCENT DYES | ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC. (US) | 2013-04-11 | — | — | US | disclosed |
| US-20130089853-A1 | FLUORESCENT DYES | ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC. (US) | 2013-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311846-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | BCDIN3D, EFTUD2, IK | MEN1 3646/4885THRB 4416/4885RECQL 1070/4885 |
| US-20210079034-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | BCDIN3D, EFTUD2, IK | MEN1 3646/4885THRB 4416/4885RECQL 1070/4885 |
| US-10106573-B2 | Fluorescent dyes and methods of use thereof | BCDIN3D, EFTUD2, IK | MEN1 3646/4885THRB 4416/4885RECQL 1070/4885 |
| US-20130089853-A1 | FLUORESCENT DYES | KIT, TKFC, IK | MEN1 4358/4885THRB 3185/4885RECQL 1043/4885 |
| US-10875886-B2 | Fluorescent dyes and methods of use thereof | BCDIN3D, EFTUD2, IK | MEN1 3646/4885THRB 4416/4885RECQL 1070/4885 |
| US-20190002491-A1 | FLUORESCENT DYES AND METHODS OF USE THEREOF | BCDIN3D, EFTUD2, IK | MEN1 3646/4885THRB 4416/4885RECQL 1070/4885 |
| US-11939350-B2 | Fluorescent dyes and methods of use thereof | BCDIN3D, EFTUD2, IK | MEN1 3646/4885THRB 4416/4885RECQL 1070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.